2004, Leads and Pharmaceutical products

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

JUNE 24, 2022

Stakeholders in the EU often use the risk-adjusted Net Present Value (rNPV) investment model to determine whether to invest in a pharmaceutical product. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2004. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs.

Pharmaceutical

Pharmaceutical Medicine Marketing Competition

Uri Goren

Cadensee

JULY 20, 2021

When he was going through his cancer, he died in 2004. But there's a lot of other things that bother patients and might be a target for healthcare technology, or pharmaceutical products. And second of all, you should see who leads the anti-vaxxer; it's usually doctors. So, I myself, was a care giver for my father.

Food and Drug Administration

Food and Drug Administration Doctors Healthcare Healthcare

Pharma Rep Focus

2022 spells change for EU pharmaceutical legislation

Uri Goren

Webinars

Stay Connected